Research Articles
Batch vs. Continuous API Manufacturing: A Comprehensive PMI Comparison for Pharma Development
This article provides a detailed comparison of Process Mass Intensity (PMI) between traditional batch and modern continuous manufacturing processes for Active Pharmaceutical Ingredients (APIs).
The E Factor in Pharmaceutical Chemistry: From Oil Refining to Sustainable API Synthesis
This article explores the critical application of Sheldon's Environmental (E) Factor—a metric of process waste—across chemical manufacturing scales, from bulk petrochemicals to high-value Active Pharmaceutical Ingredients (APIs).
E Factor in Green Chemistry: A Complete Guide to Calculation, Application, and Optimization for Pharmaceutical R&D
This comprehensive guide explores the E Factor (Environmental Factor), a pivotal green chemistry metric for quantifying process waste.
Catalysis Showdown: A Strategic Guide to Choosing Metal, Organo-, and Biocatalysts for Drug Discovery
This article provides a comprehensive comparison of Metal, Organo-, and Biocatalysis (the 'E Factor' trio) for researchers and drug development professionals.
Beyond Yield: A Deep Dive into Atom Economy Comparison of Diels-Alder vs Wittig Reactions in Modern Synthesis
This analytical review provides researchers, scientists, and drug development professionals with a comprehensive comparison of the Diels-Alder and Wittig reactions through the critical lens of atom economy.
100% Atom Economy in Drug Discovery: The Diels-Alder Reaction's Transformative Role
This article explores the critical application of the Diels-Alder reaction as a paradigm of 100% atom economy in pharmaceutical synthesis.
Cyrene vs DMF: A Comprehensive Performance Comparison in Organic Synthesis for Biomedical Applications
This article provides a detailed comparative analysis of Cyrene (dihydrolevoglucosenone) and Dimethylformamide (DMF) as solvents in organic synthesis, tailored for researchers and drug development professionals.
Catalytic vs. Stoichiometric API Routes: A Data-Driven Cost-Benefit Analysis for Drug Developers
This article provides a comprehensive cost-benefit analysis of catalytic versus stoichiometric routes in Active Pharmaceutical Ingredient (API) synthesis, tailored for researchers, scientists, and drug development professionals.
Mastering Continuous Oscillatory Baffled Reactors (COBRs) for Advanced API Synthesis: A Comprehensive Guide for Pharmaceutical Researchers
This article provides a detailed examination of Continuous Oscillatory Baffled Reactors (COBRs) for Active Pharmaceutical Ingredient (API) synthesis.
Greening Pharma: A Data-Driven Comparison of Traditional vs. Green Solvents in API Synthesis PMI
This article provides a comprehensive analysis for researchers and pharmaceutical development professionals on the critical transition from traditional to green solvents in Active Pharmaceutical Ingredient (API) synthesis.